• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

天冬氨酸门作为细菌黏附素 FimH 受体结合部位的潜在熵杠杆。

The tyrosine gate as a potential entropic lever in the receptor-binding site of the bacterial adhesin FimH.

机构信息

Structural Molecular Microbiology, Vrije Universiteit Brussel, VIB, Brussels, Belgium.

出版信息

Biochemistry. 2012 Jun 19;51(24):4790-9. doi: 10.1021/bi300251r. Epub 2012 Jun 7.

DOI:10.1021/bi300251r
PMID:22657089
Abstract

Uropathogenic Escherichia coli (UPEC) are the major causative agents of urinary tract infections. During infection, UPEC adhere to mannosylated glycoreceptors on the urothelium via the FimH adhesin located at the tip of type 1 pili. Synthetic FimH antiadhesives such as alkyl and phenyl α-D-mannopyranosides are thus ideal candidates for the chemical interception of this crucial step in pathogenesis. The crystal structures of the FimH lectin domain in its ligand-free form and in complexes with eight medium- and high-affinity mannopyranoside inhibitors are presented. The thermodynamic profiles of the FimH-inhibitor interactions indicate that the binding of FimH to α-D-mannopyranose is enthalpy-driven and has a negative entropic change. Addition of a hydrophobic aglycon influences the binding enthalpy and can induce a favorable entropic change. The alleviation of the entropic cost is at least in part explained by increased dynamics in the tyrosine gate (Tyr48 and Tyr137) of the FimH receptor-binding site upon binding of the ligand. Ligands with a phenyl group directly linked to the anomeric oxygen of α-D-mannose introduce the largest dynamics into the Tyr48 side chain, because conjugation with the anomeric oxygen of α-D-mannose forces the aromatic aglycon into a conformation that comes into close contact (≈2.65 Å) with Tyr48. A propargyl group in this position predetermines the orientation of the aglycon and significantly decreases affinity. FimH has the highest affinity for α-D-mannopyranosides substituted with hydrophobic aglycons that are compatible in shape and electrostatic properties to the tyrosine gate, such as heptyl α-D-mannose.

摘要

尿路致病性大肠杆菌(UPEC)是尿路感染的主要病原体。在感染过程中,UPEC 通过位于 1 型菌毛尖端的 FimH 黏附素与尿路上皮中的甘露糖基糖受体结合。因此,合成的 FimH 抗黏附剂,如烷基和苯基 α-D-甘露吡喃糖苷,是化学阻断发病机制这一关键步骤的理想候选物。本文呈现了 FimH 凝集素结构域在无配体形式和与 8 种中亲和和高亲和性甘露吡喃糖苷抑制剂复合物的晶体结构。FimH-抑制剂相互作用的热力学谱表明,FimH 与 α-D-甘露吡喃糖的结合是焓驱动的,伴有负的熵变。疏水性非糖部分的添加会影响结合焓,并能诱导有利的熵变。配体与 FimH 受体结合位点的酪氨酸门(Tyr48 和 Tyr137)结合时,增加的动力学至少部分解释了熵成本的缓解。与 α-D-甘露糖的端基氧直接相连的苯基基团会使 Tyr48 侧链引入最大的动力学,因为与 α-D-甘露糖的端基氧的共轭迫使芳基非糖部分进入与 Tyr48 紧密接触(≈2.65 Å)的构象。该位置的炔丙基基团预先确定了非糖部分的取向,并显著降低了亲和力。FimH 对疏水性非糖部分取代的 α-D-甘露吡喃糖苷具有最高的亲和力,这些非糖部分在形状和静电特性上与酪氨酸门相容,如庚基 α-D-甘露糖。

相似文献

1
The tyrosine gate as a potential entropic lever in the receptor-binding site of the bacterial adhesin FimH.天冬氨酸门作为细菌黏附素 FimH 受体结合部位的潜在熵杠杆。
Biochemistry. 2012 Jun 19;51(24):4790-9. doi: 10.1021/bi300251r. Epub 2012 Jun 7.
2
Receptor binding studies disclose a novel class of high-affinity inhibitors of the Escherichia coli FimH adhesin.受体结合研究揭示了一类新型的大肠杆菌FimH粘附素高亲和力抑制剂。
Mol Microbiol. 2005 Jan;55(2):441-55. doi: 10.1111/j.1365-2958.2004.04415.x.
3
Study of the structural and dynamic effects in the FimH adhesin upon α-d-heptyl mannose binding.研究 FimH 黏附素与α-d-庚基甘露糖结合时的结构和动态效应。
J Med Chem. 2014 Feb 27;57(4):1416-27. doi: 10.1021/jm401666c. Epub 2014 Feb 7.
4
Intervening with urinary tract infections using anti-adhesives based on the crystal structure of the FimH-oligomannose-3 complex.基于FimH-低聚甘露糖-3复合物晶体结构,使用抗黏附剂干预尿路感染。
PLoS One. 2008 Apr 30;3(4):e2040. doi: 10.1371/journal.pone.0002040.
5
The affinity of the FimH fimbrial adhesin is receptor-driven and quasi-independent of Escherichia coli pathotypes.FimH菌毛粘附素的亲和力由受体驱动,且与大肠杆菌致病型基本无关。
Mol Microbiol. 2006 Sep;61(6):1556-68. doi: 10.1111/j.1365-2958.2006.05352.x. Epub 2006 Aug 23.
6
FimH antagonists: structure-activity and structure-property relationships for biphenyl α-D-mannopyranosides.FimH 拮抗剂:联苯-α-D-甘露吡喃糖苷的结构-活性和结构-性质关系。
ChemMedChem. 2012 Aug;7(8):1404-22. doi: 10.1002/cmdc.201200125. Epub 2012 May 29.
7
Development of an aggregation assay to screen FimH antagonists.开发一种用于筛选 FimH 拮抗剂的聚集分析方法。
J Microbiol Methods. 2010 Sep;82(3):249-55. doi: 10.1016/j.mimet.2010.06.015. Epub 2010 Jul 8.
8
Kinetic properties of carbohydrate-lectin interactions: FimH antagonists.碳水化合物-凝集素相互作用的动力学特性:FimH 拮抗剂。
ChemMedChem. 2014 Jan;9(1):78-83. doi: 10.1002/cmdc.201300349. Epub 2013 Dec 2.
9
Target Selectivity of FimH Antagonists.FimH 拮抗剂的靶标选择性。
J Med Chem. 2012 Nov 26;55(22):9810-6. doi: 10.1021/jm3010338. Epub 2012 Nov 1.
10
Evaluation of the carbohydrate recognition domain of the bacterial adhesin FimH: Design, synthesis and binding properties of mannoside ligands.细菌黏附素FimH碳水化合物识别结构域的评估:甘露糖苷配体的设计、合成及结合特性
Org Biomol Chem. 2006 Nov 7;4(21):3913-22. doi: 10.1039/b610745a. Epub 2006 Sep 25.

引用本文的文献

1
Bivalent Inhibitors of Mannose-Specific Bacterial Adhesion: A Xylose-Based Conformational Switch to Control Glycoligand Distance.甘露糖特异性细菌黏附的二价抑制剂:基于木糖的构象开关以控制糖配体距离。
Molecules. 2025 Jul 23;30(15):3074. doi: 10.3390/molecules30153074.
2
Orthogonal photoswitching of heterobivalent azobenzene glycoclusters: the effect of glycoligand orientation in bacterial adhesion.异二价偶氮苯糖簇的正交光开关:糖配体取向对细菌黏附的影响
Beilstein J Org Chem. 2025 Apr 8;21:736-748. doi: 10.3762/bjoc.21.57. eCollection 2025.
3
Structure-based design of an immunogenic, conformationally stabilized FimH antigen for a urinary tract infection vaccine.
基于结构设计用于尿路感染疫苗的免疫原性、构象稳定的FimH抗原。
PLoS Pathog. 2025 Feb 19;21(2):e1012325. doi: 10.1371/journal.ppat.1012325. eCollection 2025 Feb.
4
Cloning and Expression of Pigeon-Derived Type 1 Pilus Clusters and Analysis of Amino Acid Sequence Characteristics of Functional Proteins.鸽源Ⅰ型菌毛簇的克隆与表达及功能蛋白氨基酸序列特征分析。
Genes (Basel). 2024 Sep 26;15(10):1253. doi: 10.3390/genes15101253.
5
Conformational ensembles in FimH impact uropathogenesis.FimH 构象集合影响尿路致病性。
Proc Natl Acad Sci U S A. 2024 Sep 24;121(39):e2409655121. doi: 10.1073/pnas.2409655121. Epub 2024 Sep 17.
6
Does size matter? - Comparing pyranoses with septanoses as ligands of the bacterial lectin FimH.尺寸是否重要?——将吡喃糖和庚糖作为细菌凝集素 FimH 的配体进行比较。
Eur J Med Chem. 2024 Mar 15;268:116225. doi: 10.1016/j.ejmech.2024.116225. Epub 2024 Feb 8.
7
Glycomimetics for the inhibition and modulation of lectins.糖基模拟物抑制和调节凝集素。
Chem Soc Rev. 2023 Jun 6;52(11):3663-3740. doi: 10.1039/d2cs00954d.
8
Allosteric Regulation of Glycogen Phosphorylase by Order/Disorder Transition of the 250' and 280s Loops.别构调节糖原磷酸化酶通过 250' 和 280s 环的有序/无序转变。
Biochemistry. 2023 Apr 18;62(8):1360-1368. doi: 10.1021/acs.biochem.2c00671. Epub 2023 Mar 29.
9
Insightful Improvement in the Design of Potent Uropathogenic FimH Antagonists.强效尿路致病性菌毛H拮抗剂设计的深刻改进
Pharmaceutics. 2023 Feb 4;15(2):527. doi: 10.3390/pharmaceutics15020527.
10
Neutralizing Antibodies Against Allosteric Proteins: Insights From a Bacterial Adhesin.针对别构蛋白的中和抗体:来自细菌黏附素的见解。
J Mol Biol. 2022 Sep 15;434(17):167717. doi: 10.1016/j.jmb.2022.167717. Epub 2022 Jul 4.